SmartNuclide

Technology

Dedicated to pioneering the development and application of innovative nuclear medicine diagnostic and therapeutic drugs

Phase I Study of 99mTc-ADAPT6, a Scaffold Protein–Based Probe for Visualization of HER2 Expression in Breast Cancer

2022年6月2日

Phase I Study of 99mTc-ADAPT6, a Scaffold Protein–Based Probe for Visualization of HER2 Expression in Breast Cancer

https://doi.org/10.2967/jnumed.120.248799